• Contact Us
  • Indexing
  • Submit Manuscript
  • Open Access
  • Journals
  • Home
  • ISSN: 2379-948X
    Volume 4, Issue 2
    Case Report
    Martin Villares C*, Gonzalez Gimeno MJ, Diez Gonzalez L, San Roman Carbajo J, Dominguez Calvo J, Valor Garcia C, Arguello de Tomas M
    From the first laryngectomy performed by Billroth, pharyngocutaneous fistula has not been eradicated. Modern reconstructive techniques can solve almost any surgical problem in laryngectomy patients, but morbidity is still high in critical patients. In a effort to minimize morbilitity in unhealthy patients, we used the surgical pharyngostoma technique as conservative approach for complex postlaryngectomy fistulas in selected patients, in which, aggressive surgical interventions were not safe.
    Jeffrey P Marino* and Adam M Klein
    Laryngeal papillomatosis is a recurrent condition typically manifesting as benign epithelial lesions affecting glottic closure and vocal fold mucosal wave propagation. This case describes a subepithelial deposit of papilloma which developed as a complication of prior surgical interventions that disrupted the vocal fold epithelium and violated its microarchitecture.
    Research Article
    Jared J. Tompkins*, Philip Rosen, Jennifer D. McLevy, and Jerome W. Thompson
    Posterior glottis stenosis (PGS) represents an interesting dilemma to the airway surgeon. Diagnosis of this rare condition can be difficult, often mimicking bilateral vocal fold paralysis. Management can also be challenging, with several potential therapeutic options. After receiving IRB approval, pediatric Otolaryngology patient records at a single institution in Memphis, TN were reviewed from 1/1/2013 to 7/1/2014 and 4 patients were identified with PGS. Serendipitously, each these 4 patients represented a distinct grade, I-IV, of PGS. Our case series presents these pediatric patients, all withconfirmed PGS on operative direct laryngoscopy that were treated with Triamcinolone 40 mg/ 1mL injectable solution a variable number of times, based on therapeutic response. All 4 patients showed improvement or resolution of synechiae causing the PGS on subsequent laryngoscopy. Triamcinolone injection has previously been shown to be a viable first-line therapeutic option for the treatment of low-grade (type I-II) PGS. Based on our limited series, a trial of steroid injection may represent a standalone therapeutic option worth trial for higher grade (type III-IV) PGS prior to more aggressive surgical treatment such as cartilage grafting, which is the standard practice at this time.
    Sunil K. Rout*, Subhendu Singh, and Sanujeet Mantry
    Purpose: A prospective study of patients being treated for fracture mandible with miniplate fixation plus two weeks of Intermaxillary fixation was designed. The purpose of this study was to establish the better outcome with this technique mainly in terms of occlusion, good osteosynthesis and lesser complication.
    Patients and Methods: From April 2010 to June 2013 we treated 31 patients who fit to the laid down criteria. They had a total of 42 fractures in their mandible. The fractures were fixed with 2.0 mm non-locking miniplates and screws as per the Champy's principles of ideal osteosynthesis. It was supplemented by 2 weeks of Intermaxillary fixation post operatively. They were followed up for a minimum period of 6 weeks. The outcome was assessed in terms of occlusion, implant site infection and mouth opening.
    Results: Only one of these patients (3%) ended up with a poor occlusion which would require a surgical correction. All of them had adequate (> 3.0cm) inter-incisor opening by the end of their treatment and 3 of them (9.6%) developed infection at the implant site which could be managed with antibiotics and local wound care.
    Conclusion: Supplemental IMF for 2 weeks following miniplate fixation along the Champy's lines of osteosynthesis yields better outcome in cases of fracture mandible.
    Short Communication
    David L. Walner*, and Daniel B. Neumann
    Objective: To evaluate existing classification systems for laryngomalacia and describe a more complete and comprehensive system
    Methods: We searched the literature for previously described classification systems for laryngomalacia. We attempted to use each of these systems to classify a cohort of patients, but were unsuccessful due to deficiencies in each system. We subsequently developed a novel system which allows comprehensive and accurate classification of patients with laryngomalacia.
    Results: We identified 6 existing systems to classify laryngomalacia. After trying to use these existing systems to classify a cohort of patients, we identified deficiencies with each system. We then created our own system which defines four major categories based on anatomical and pathophysiological variations. LM1 refers to anterior prolapse of the posterior (arytenoid) structures. It is subdivided into LM1a which describes prolapse of mucosa and cuneiform cartilage, and LM1b which also includes prolapse of the larger corniculate and arytenoid cartilages. LM2 describes short aryepiglottic folds. LM3 is comprised of anatomical abnormalities of the epiglottis. It is subdivided to describe a curled, tubular, or long epiglottis (LM3a), a posterior petiole (LM3b), or posterior epiglottic collapse (LM3c). LM4 refers to generalized collapse of the supraglottic structures.
    Conclusion: Current classification systems to describe laryngomalacia have many deficiencies. Our newly described classification system more accurately portrays the anatomical and physiologic variations found in laryngomalacia.
  • JSciMed Central Blogs
  • JSciMed Central welcomes back astronaut Scott Kelly and cosmonaut Mikhail Kornienko.
    Readmore...

    Wonder Women Tech not only disrupted the traditional conference model but innovatively changed the way conferences should be held.
    Readmore...

    JSciMed Central Peer-reviewed Open Access Journals
    10120 S Eastern Ave, Henderson,
    Nevada 89052, USA
    Tel: (702)-751-7806
    Toll free number: 1-800-762-9856
    Fax: (844)-572-4633 (844-JSCIMED)
    E-mail: otolaryngology@jscimedcentral.com
    1455 Frazee Road, Suite 570
    San Diego, California 92108, USA
    Tel: (619)-373-8720
    Toll free number: 1-800-762-9856
    Fax: (844)-572-4633 (844-JSCIMED)
    E-mail: otolaryngology@jscimedcentral.com
    About      |      Journals      |      Open Access      |      Special Issue Proposals      |      Guidelines      |      Submit Manuscript      |      Contacts
    Copyright © 2016 JSciMed Central All Rights Reserved
    Creative Commons Licence Open Access Publication by JSciMed Central is licensed under a Creative Commons Attribution 4.0 International License.
    Based on a work at https://jscimedcentral.com/. Permissions beyond the scope of this license may be available at https://creativecommons.org/.